C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 401/14 (2006.01) A61K 31/4439 (2006.01) A61P 1/04 (2006.01)
Patent
CA 2674358
The invention relates to crystalline forms of various solvates of ilaprazole, 2[[(4-methoxy-3- methyl-2-pyridinyl)-methyl]sulfinyl]-5-(lH-pyrrol-l-yl) 1H-Benzimidazole. The invention also relates to a pharmaceutical composition for inhibiting gastric acid secretion comprising crystalline ilaprazole hydrate according to the invention in an amount effective to inhibit gastric acid secretion and a pharmaceutically acceptable carrier. The invention also provides methods of treatment for various acid-related gastrointestinal (GI) disorders.
L'invention concerne des formes cristallines de divers solvates d'ilaprazole, le 2[[(4-méthoxy-3- méthyl-2-pyridinyl)-méthyl]sulfinyl]-5-(lH-pyrrol-l-yl) 1H-Benzimidazole. L'invention concerne également une composition pharmaceutique pour inhiber la sécrétion d'acide gastrique comprenant un hydrate d'ilaprazole cristallin selon l'invention en une quantité efficace pour inhiber la sécrétion d'acide gastrique et un véhicule pharmaceutiquement acceptable. L'invention concerne également des procédés de traitement pour divers troubles gastro-intestinaux liés aux acides (GI).
Brackett John M.
Jonaitis David T.
Lai Wei
Parent Stephan D.
Dennison Associates
Il Yang Pharmaceutical Company Ltd.
LandOfFree
Crystalline forms of solvated ilaprazole does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Crystalline forms of solvated ilaprazole, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Crystalline forms of solvated ilaprazole will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1850725